Additional Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Indiana University
    Indianapolis IN. 46202
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    University of Cincinnati Medical Center
    Cincinnati OH. 45267
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Baylor College of Medicine
    Houston TX. 77030
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Icahn School of Medicine at Mount Sinai
    New York NY. 10029
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    University of Utah
    Salt Lake City UT. 84108
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Cedars Sinai Medical Center
    Los Angeles CA. 90048
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Cleveland Clinic Florida
    Weston FL. 33331
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    University of North Carolina at Chapel Hill
    Chapel Hill NC. 27514
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    National Jewish Health
    Denver CO. 80206
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Yale University School of Medicine
    New Haven CT. 06511
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    University of Kansas Medical Center
    Kansas City MO. 66160
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Henry Ford Health
    Detroit MI. 48202
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Medical University of South Carolina
    Charleston SC. 29425
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Paradigm Clinical Research Centers, LLC
    San Diego CA. 92108
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    UAB Lung Health Center
    Birmingham AL. 35233
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    The Lung Research Center, LLC
    Chesterfield MO. 63017
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    El Paso Pulmonary Association
    El Paso TX. 79902
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Temple Health - Oaks
    Phoenixville PA. 19460
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Temple University Hospital - Main Campus
    Philadelphia PA. 19140
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Yale University
    New Haven CT. 06519
    View Details